265
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Exosomes Represent an Immune Suppressive T Cell Checkpoint in Human Chronic Inflammatory Microenvironments

ORCID Icon, ORCID Icon, , , &

References

  • Agrawal S, Marquet J, Delfau-Larue MH, Copie-Bergman C, Jouault H, Reyes F, Bensussan A, Farcet JP. 1998. CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs. J Clin Invest. 102(9):1715–23.
  • Anel A, Gallego-Lleyda A, de Miguel D, Naval J, Martinez-Lostao L. 2019. Role of exosomes in the regulation of T-cell mediated immune responses and in autoimmune disease. Cells. 8(2):154.
  • Baba S, Kagoya R, Kondo K, Suzukawa M, Ohta K, Yamasoba T. 2015. T-cell phenotypes in chronic rhinosinusitis with nasal polyps in Japanese patients. Allergy Asthma Clin Immunol. 11(1):33.
  • Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, Ahmed R. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 439(7077):682–87.
  • Bernstein JM, Ballow M, Rich G, Allen C, Swanson M, Dmochowski J. 2004. Lymphocyte subpopulations and cytokines in nasal polyps: is there a local immune system in the nasal polyp? Otolaryngol Head Neck Surg. 130(5):526–35.
  • Bernstein JM, Broderick L, Parsons RR, Bankert RB. 2006. Human nasal polyp microenvironment maintained in viable and functional states as xenografts in SCID mice. Ann Otol Rhinol Laryngol. 115(1):65–73.
  • Bernstein JM, Brooks SP, Lehman HK, Pope L, Sands A, Shultz LD, Bankert RB. 2009. Human nasal polyp microenvironments maintained in a viable and functional state as xenografts in NOD-SCID IL2rgamma(null) mice. Ann Otol Rhinol Laryngol. 118(12):866–75.
  • Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A, Betts MR, Freeman GJ, Vignali DA, Wherry EJ. 2009. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol. 10(1):29–37.
  • Broderick L, Brooks SP, Takita H, Baer AN, Bernstein JM, Bankert RB. 2006. IL-12 reverses anergy to T cell receptor triggering in human lung tumor-associated memory T cells. Clin Immunol. 118(2–3):159–69.
  • Broderick L, Yokota SJ, Reineke J, Mathiowitz E, Stewart CC, Barcos M, Kelleher RJ Jr., Bankert RB. 2005. Human CD4+ effector memory T cells persisting in the microenvironment of lung cancer xenografts are activated by local delivery of IL-12 to proliferate, produce IFN-gamma, and eradicate tumor cells. J Immunol. 174(2):898–906.
  • Cho SH, Kim DW, Gevaert P. 2016. Chronic rhinosinusitis without nasal polyps. J Allergy Clin Immunol Pract. 4(4):575–82.
  • Crawford A, Wherry EJ. 2009. The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses. Curr Opin Immunol. 21(2):179–86.
  • Dagur PK, Sharma B, Kumar G, Khan NA, Katoch VM, Sengupta U, Joshi B. 2010. Mycobacterial antigen(s) induce anergy by altering TCR- and TCR/CD28-induced signalling events: insights into T-cell unresponsiveness in leprosy. Mol Immunol. 47(5):943–52.
  • Feunou P, Poulin L, Habran C, Le Moine A, Goldman M, Braun MY. 2003. CD4+CD25+ and CD4+CD25- T cells act respectively as inducer and effector T suppressor cells in superantigen-induced tolerance. J Immunol. 171(7):3475–84.
  • Fourcade J, Sun Z, Pagliano O, Guillaume P, Luescher IF, Sander C, Kirkwood JM, Olive D, Kuchroo V, Zarour HM. 2012. CD8+ T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1. Cancer Res. 72(4):887–96.
  • Hong CS, Funk S, Muller L, Boyiadzis M, Whiteside TL. 2016. Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer. J Extracell Vesicles. 5(1):29289.
  • Hu HL, Cornwell WD, Rogers TJ, Lin YS. 1996. In vivo analysis of a superantigen-induced T cell suppressor factor. Cell Immunol. 167(2):285–92.
  • Ickrath P, Kleinsasser N, Ding X, Ginzkey C, Beyersdorf N, Hagen R, Kerkau T, Hackenberg S. 2017. Characterization of T-cell subpopulations in patients with chronic rhinosinusitis with nasal polyposis. Allergy Rhinol (Providence). 8(3):139–47.
  • Jelley-Gibbs DM, Dibble JP, Filipson S, Haynes L, Kemp RA, Swain SL. 2005. Repeated stimulation of CD4 effector T cells can limit their protective function. J Exp Med. 201(7):1101–12.
  • Jiang Y, Li Y, Zhu B. 2015. T-cell exhaustion in the tumor microenvironment. Cell Death Dis. 6(6):e1792.
  • Jin HT, Anderson AC, Tan WG, West EE, Ha SJ, Araki K, Freeman GJ, Kuchroo VK, Ahmed R. 2010. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A. 107:14733–38.
  • Joller N, Hafler JP, Brynedal B, Kassam N, Spoerl S, Levin SD, Sharpe AH, Kuchroo VK. 2011. Cutting edge: TIGIT has T cell-intrinsic inhibitory functions. J Immunol. 186(3):1338–42.
  • Kelleher RJ Jr., Balu-Iyer S, Loyall J, Sacca AJ, Shenoy GN, Peng P, Iyer V, Fathallah AM, Berenson CS, Wallace PK, et al. 2015. Extracellular vesicles present in human ovarian tumor microenvironments induce a phosphatidylserine-dependent arrest in the T-cell signaling cascade. Cancer Immunol Res. 3(11):1269–78.
  • Keller S, Konig AK, Marme F, Runz S, Wolterink S, Koensgen D, Mustea A, Sehouli J, Altevogt P. 2009. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett. 278(1):73–81.
  • Lasser C, O’Neil SE, Shelke GV, Sihlbom C, Hansson SF, Gho YS, Lundback B, Lotvall J. 2016. Exosomes in the nose induce immune cell trafficking and harbour an altered protein cargo in chronic airway inflammation. J Transl Med. 14(1):181.
  • Lehman HK, Simpson-Abelson MR, Conway TF Jr., Kelleher RJ Jr., Bernstein JM, Bankert RB. 2012. Memory T cells in the chronic inflammatory microenvironment of nasal polyposis are hyporesponsive to signaling through the T cell receptor. J Assoc Res Otolaryngol. 13(3):423–35.
  • Letvin NL, Walker BD. 2003. Immunopathogenesis and immunotherapy in AIDS virus infections. Nat Med. 9(7):861–66.
  • Mueller SK, Nocera AL, Dillon ST, Gu X, Wendler O, Otu HH, Libermann TA, Bleier BS. 2019. Noninvasive exosomal proteomic biosignatures, including cystatin SN, peroxiredoxin-5, and glycoprotein VI, accurately predict chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 9:177–86.
  • Mueller SK, Nocera AL, Dillon ST, Wu D, Libermann TA, Bleier BS. 2018. Highly multiplexed proteomic analysis reveals significant tissue and exosomal coagulation pathway derangement in chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 8:1438–44.
  • Mueller SN, Ahmed R. 2009. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A. 106(21):8623–28.
  • Muller L, Mitsuhashi M, Simms P, Gooding WE, Whiteside TL. 2016. Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets. Sci Rep. 6(1):20254.
  • Newton JR, Ah-See KW. 2008. A review of nasal polyposis. Ther Clin Risk Manag. 4:507–12.
  • Nocera AL, Miyake MM, Seifert P, Han X, Bleier BS. 2017. Exosomes mediate interepithelial transfer of functional P-glycoprotein in chronic rhinosinusitis with nasal polyps. Laryngoscope. 127(9):E295–E300.
  • Oiseth SJ, Aziz MS. 2017. Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead. J Cancer Metastasis Treat. 3(10):250.
  • Olenchock BA, Guo R, Carpenter JH, Jordan M, Topham MK, Koretzky GA, Zhong XP. 2006. Disruption of diacylglycerol metabolism impairs the induction of T cell anergy. Nat Immunol. 7(11):1174–81.
  • Pant H, Hughes A, Miljkovic D, Schembri M, Wormald P, Macardle P, Grose R, Zola H, Krumbiegel D. 2013. Accumulation of effector memory CD8+ T cells in nasal polyps. Am J Rhinol Allergy. 27(5):e117–26.
  • Peggs KS, Quezada SA, Allison JP. 2008. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy. Immunol Rev. 224:141–65.
  • Roma-Rodrigues C, Fernandes AR, Baptista PV. 2014. Exosome in tumour microenvironment: overview of the crosstalk between normal and cancer cells. Biomed Res Int. 2014:179486.
  • Ryan MW, Davis LS. 2010. T cells in chronic rhinosinusitis with nasal polyposis. Curr Opin Otolaryngol Head Neck Surg. 18(3):200–05.
  • Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401(6754):708–12.
  • Sanchez-Segura A, Brieva JA, Rodriguez C. 1998. T lymphocytes that infiltrate nasal polyps have a specialized phenotype and produce a mixed TH1/TH2 pattern of cytokines. J Allergy Clin Immunol. 102(6):953–60.
  • Shenoy GN, Loyall J, Berenson CS, Kelleher RJ Jr., Iyer V, Balu-Iyer SV, Odunsi K, Bankert RB. 2018a. Sialic acid-dependent inhibition of T cells by exosomal ganglioside GD3 in Ovarian Tumor Microenvironments. J Immunol. 201(12):3750–58.
  • Shenoy GN, Loyall J, Maguire O, Iyer V, Kelleher RJ Jr., Minderman H, Wallace PK, Odunsi K, Balu-Iyer SV, Bankert RB. 2018b. Exosomes associated with human ovarian tumors harbor a reversible checkpoint of T-cell responses. Cancer Immunol Res. 6(2):236–47.
  • Simpson-Abelson MR, Loyall JL, Lehman HK, Barnas JL, Minderman H, O’Loughlin KL, Wallace PK, George TC, Peng P, Kelleher RJ Jr., et al. 2013. Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-kappaB and NFAT signaling in tumor-associated T cells. Cancer Immun. 13:14.
  • Sommer JR. 1977. To cationize glass. J Cell Biol. 75:A245–A.
  • Szajnik M, Derbis M, Lach M, Patalas P, Michalak M, Drzewiecka H, Szpurek D, Nowakowski A, Spaczynski M, Baranowski W, et al. 2013. Exosomes in plasma of patients with ovarian carcinoma: potential biomarkers of tumor progression and response to therapy. Gynecol Obstet (Sunnyvale) Suppl. 4:3.
  • Thery C, Amigorena S, Raposo G, Clayton A. 2006. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol Chapter. 3. Unit 3 22:1–29.
  • Wherry EJ. 2011. T cell exhaustion. Nat Immunol. 12(6):492–99.
  • Whiteside TL. 2016. Exosomes and tumor-mediated immune suppression. J Clin Invest. 126(4):1216–23.
  • Xie Y, Zhang X, Zhao T, Li W, Xiang J. 2013. Natural CD8(+)25(+) regulatory T cell-secreted exosomes capable of suppressing cytotoxic T lymphocyte-mediated immunity against B16 melanoma. Biochem Biophys Res Commun. 438(1):152–55.
  • Yang C, Robbins PD. 2012. Immunosuppressive exosomes: a new approach for treating arthritis. Int J Rheumatol. 2012:573528.
  • Zhang W, Zhang J, Cheng L, Ni H, You B, Shan Y, Bao L, Wu D, Zhang T, Yue H, et al. 2018. A disintegrin and metalloprotease 10-containing exosomes derived from nasal polyps promote angiogenesis and vascular permeability. Mol Med Rep. 17(4):5921–27.
  • Zhong XP, Hainey EA, Olenchock BA, Jordan MS, Maltzman JS, Nichols KE, Shen H, Koretzky GA. 2003. Enhanced T cell responses due to diacylglycerol kinase zeta deficiency. Nat Immunol. 4(9):882–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.